期刊文献+

冠状动脉旁路移植术病人神经体液因子的变化 被引量:4

The study of neurohormonal factors during the perioperative period of coronary artery disease
原文传递
导出
摘要 目的 检测具有高危因素的行冠状动脉旁路移植术(CABG)病人的相关神经体液因子,结合临床改变,寻找针对性的处理措施及依据,减少并发症。方法 48例病人分A组23例行体外循环冠状动脉旁路移植术(CCABG);B组25例行非体外循环冠状动脉旁路移植术(OPCAB)。围术期分6个时间点测定血浆中血管紧张素Ⅱ(AGⅡ)、醛固酮(ALD)、心钠素(ANP)、胰岛素(INS)、血糖(SUG)和肌钙蛋白Ⅰ(cTnⅠ)。结果 血浆AGⅡ水平,A组术后6h、B组术后3h达高峰。血浆ALl)水平,A组术后6h、B组在术后0h达高峰。血浆ANP水平,A组术后0h、B组术中已达高峰。血浆胰岛素水平,A组术后24h、B组术后6h达高峰,术后24hA组显著高于B组。血糖水平,A组术后3h、B组术后0h达高峰。血浆AGⅡ、ALD、ANP和血糖水平术中及以后各时点A组均显著高于B组。血浆cTnⅠ水平,术后3—24hA组显著高于B组。结论 CABG均可出现血糖升高的高渗性利尿和高醛固酮血症的利尿,CCABG组是二者同时升高出现强而持久的利尿,OPCAB组则以高渗性利尿为主,持续时间短。CABG,尤其CCABG应使用血管紧张素转换酶抑制剂(ACEI)、AGⅡ受体拈抗剂(ARB)和抗醛固酮制剂;术后6h内更应降血糖,补充钾、镁制剂。 Objective To study the change of neurohormonal factors during CABG and find the effective perioporative treatments for coronary artery disease patients with high-risks. Methods Forty-eight patients were divided into on-pump CABG group (group A, n = 23) and off-pump CABG group(group B, n = 25). The clinical results were observed and blood samples were collected at six time-points. Angiotensin Ⅱ(AG Ⅱ), aldosterone(ALD), atrial natriuretie peptide (ANP), insulin, glucose and eTnI levels in plasma were measured respectively. Results The AG Ⅱ levels in plasma increased in both groups and reached the peak at 6 h after operation in group A and 3 h after oporatlon in group B, respectively. The peak level of ALD in plasma were at 6 h in group A, and 0 h in group B. The level of ANP in plasma was highest at 0 h in group A, and at the midopemtion in group B. The insulin level in plasma was highest at 24 h in group A and at 6 h in group B. The insulin level at 24 h in group A was significantly higher than that in group B. The glucose level reached the peak at 3 h after operation in group A and at 0 h after operation in group B. The levels of AG Ⅱ, ALD, ANP and glucose in plasma in group A were significantly higher than those in group B at any time-point. The cTnI levels were highest at 24 h in both groups. The cTnⅠ levels in group A were significantly higher than group B at time-points. Conclusion CABG can produce hyperesmotic urinative effects and hyperaldosteronism, which in CABG group is strong and persistent effects due to the hyperosmotic urinative effects and hyperaldosteronism. In OPCAB group is light and short urinative effects mainly due to the hyperosmotic. ACEI, ARB and aldosterone antagonists should be used during the perioperation of CABG. During the early postoperative period, the plasma glucose should be well controlled and GIK solution with magnesium is needed.
出处 《中华胸心血管外科杂志》 CSCD 北大核心 2006年第2期115-117,共3页 Chinese Journal of Thoracic and Cardiovascular Surgery
关键词 冠状动脉分流术 血管紧张素Ⅱ 醛固酮 心钠素 胰岛素 肌钙蛋白Ⅰ Coronary artery bypass Angiotensin Ⅱ Aldosterone Atrial natriuretic factor Insulin Troponin Ⅰ
  • 相关文献

参考文献8

  • 1Gao D,Gnmwald GK,Rumsfeld JS,et al.Variation in mortality risk factors with time after coronary artery bypass graft operation.Ann Thorac Surg,2003,75:74-81.
  • 2Shroyer ALW,Plomondon ME,Grover FL,et al.The 1996 coronary artery bypass risk model:the society of thoracic surgeons adult cardiac national database.Ann Thorac Surg,1999,67:1205-1208.
  • 3Neri S,Boddi M,Modesti PA,et al.Cardiac angiotensin Ⅱ participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.Circ Res,2004,94:1630-1637.
  • 4Pretorius M,Murphey L J,McFarlane JA,et al.Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.Circulation,2003,108:3079-3083.
  • 5Slight SH,Joseph J,Ganjam VK,et al.Extra-adrenal mineralocorticoids and cardiovascular tissue.J Mol Cell Cardiol,1999,31:1175-1184.
  • 6Sezai A,Shiono M,Orime Y,et al.Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery.Ann Thorac Surg,2000,69:732-738.
  • 7Song MH,Kobayashi Y,Michi H.Clinical implication of atrial and brain natriuretic peptide in coronary artery bypass grafting.Asian Cardiovasc Thorac Ann,2004,12:41-46.
  • 8Kuntschen FR,Galletti PM,Hahn C,et al.Alterations of insulin and glucose metabolism during cardiopulmonary bypass under normothermia.J Thorac Cardiovasc Surg,1985,89:97-106.

同被引文献33

  • 1中国心血管健康与疾病报告编写组,王增武,胡盛寿.中国心血管健康与疾病报告2019概要[J].中华老年病研究电子杂志,2020(4):4-15. 被引量:997
  • 2王小启,胡盛寿,姜睿,路天宜,刘楠,姚康宝.冠状动脉旁路移植术后ST-T改变的临床意义及评价[J].中国循环杂志,2004,19(4):276-278. 被引量:1
  • 3李斌,赵文增,王亚宏,李宏伟.非体外循环与常规体外循环冠状动脉旁路移植术围手术期心肌肌钙蛋白I的变化[J].郑州大学学报(医学版),2006,41(2):365-367. 被引量:5
  • 4Sudoh T, Kangawa K,Minamina N,et al. A new natriuretic peptide in porcine brain. Nature ,1988 , 332 (6159): 78-81.
  • 5Clerico A, lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic pcptide hormones in humans. Horm Metab Res, 1999,31:487-498.
  • 6吴波 张书富.B型利钠肽与心血在管疾病研究进展[J].中国现代内科学杂志,2006,3(9):991-994.
  • 7Reyes G, Fores G, Hugo Rodriguez-abella R ,et al. NT-proBNP in cardiac surgery:a new tool for the management of our patient. Interactive Cardio Vas Thorac Surg,2005,4( 3 ) :242-247.
  • 8Morimoto K, Mort T, lshiguro S,et al. Perioperative changes in plasma brain natriuretie peptide concentrations in patients undergoing cardiac surgery. Surg Today, 1998,28 ( 1 ) : 23-29.
  • 9Mukoyama M,Nakao K, Hosoda K,et al. Brain natriuretie peptide as a novel cardiac houmone in humans. Evidence for an exquisite dual natriuretic peptide system,artrial natriuretic peplide and brain natriuretic peptide. Clinnical Investigation, 1997,87(4) , 1402-1412.
  • 10Pfister R, Schneider CA. Nalriuretic peptides BNP and NT-proBNP: established laboratory markers in clinical practice or just perspectives?. Clin Chim Acta,2004,349 ( 1-2 ) :25-38.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部